Alderman JE, Palmer J, Laws E, McCradden MD, Ordish J, Ghassemi M, Pfohl SR, Rostamzadeh N, Cole-Lewis H, Glocker B, Calvert M, Pollard TJ, Gill J, Gath J, Adebajo A, Beng J, Leung CH, Kuku S, Farmer LA, Matin RN, Mateen BA, McKay F, Heller K, Karthikesalingam A, Treanor D, Mackintosh M, Oakden-Rayner L, Pearson R, Manrai AK, Myles P, Kumuthini J, Kapacee Z, Sebire NJ, Nazer LH, Seah J, Akbari A, Berman L, Gichoya JW, Righetto L, Samuel D, Wasswa W, Charalambides M, Arora A, Pujari S, Summers C, Sapey E, Wilkinson S, Thakker V, Denniston A, and Liu X
Without careful dissection of the ways in which biases can be encoded into artificial intelligence (AI) health technologies, there is a risk of perpetuating existing health inequalities at scale. One major source of bias is the data that underpins such technologies. The STANDING Together recommendations aim to encourage transparency regarding limitations of health datasets and proactive evaluation of their effect across population groups. Draft recommendation items were informed by a systematic review and stakeholder survey. The recommendations were developed using a Delphi approach, supplemented by a public consultation and international interview study. Overall, more than 350 representatives from 58 countries provided input into this initiative. 194 Delphi participants from 25 countries voted and provided comments on 32 candidate items across three electronic survey rounds and one in-person consensus meeting. The 29 STANDING Together consensus recommendations are presented here in two parts. Recommendations for Documentation of Health Datasets provide guidance for dataset curators to enable transparency around data composition and limitations. Recommendations for Use of Health Datasets aim to enable identification and mitigation of algorithmic biases that might exacerbate health inequalities. These recommendations are intended to prompt proactive inquiry rather than acting as a checklist. We hope to raise awareness that no dataset is free of limitations, so transparent communication of data limitations should be perceived as valuable, and absence of this information as a limitation. We hope that adoption of the STANDING Together recommendations by stakeholders across the AI health technology lifecycle will enable everyone in society to benefit from technologies which are safe and effective., Competing Interests: Declaration of interests JEA is a named researcher on grants funded by the Engineering and Physical Sciences Research Council (EPSRC), the National Institute for Health and Care Research (NIHR), and the Medical Research Council (MRC); is co-organiser of the Alan Turing Institute Clinical AI Interest Group; and was an NIHR Academic Clinical Fellow from 2017 to 2020. EL is employed as a research fellow at University Hospitals Birmingham NHS Foundation Trust and received support to attend the Symposium for Artificial Intelligence Learning Health Systems conference (May, 2023). JO is an employee of Roche Diagnostics but contributed while an employee of the UK MHRA; declares support from the AIRIS 2024 committee; and has shares in Roche Group. MG is a Canadian Institute for Advanced Research (CIFAR) AI Chair, CIFAR Azrieli Global Scholar, Herman L F von Helmholtz Career Development Professor, and Jameel Clinic Affiliate, and acknowledges support from these programmes. SRP is an employee of Google Research and has stock in Google. JS is an employee of Harrison.ai. NR is an employee of Google Research. HC-L is an employee of Google and has stock or stock options in Google. DS is Acting Deputy Editor of The Lancet Digital Health, Elsevier. BG was scientific advisor for Kheiron Medical Technologies (January, 2018, to September, 2021) and has had part-time employment with stock options as part of the standard compensation package (since October, 2021); has part-time employment at HeartFlow with stock options as part of the standard compensation package (since September, 2018); and is the Royal Academy of Engineering Research Chair in Safe Deployment of Medical Imaging AI. MCa is Director of the Birmingham Health Partners Centre for Regulatory Science and Innovation, Director of the Centre for Patient Reported Outcomes Research, and an NIHR Senior Investigator. MCa, NIHR Birmingham Biomedical Research Centre, Applied Research Collaboration West Midlands, UK SPINE, Research England, the European Regional Development Fund DEMAND Hub at the University of Birmingham, the University Hospitals Birmingham NHS Foundation Trust, and the NIHR Blood and Transplant Research Unit in Precision Transplant and Cellular Therapeutics; funding from Health Data Research UK, Innovate UK (part of UKRI), Macmillan Cancer Support, UCB Pharma, GSK, Anthony Nolan, Gilead Sciences, European Commission, European Federation of Pharmaceutical Industries and Associations, Janssen, Merck, and The Brain Tumor Charity; and personal fees from Aparito, ICON, CIS Oncology, Takeda Pharmaceuticals, Merck, Daiichi Sankyo, Glaukos, GSK, Halfloop, the Patient-Centered Outcomes Research Institute (PCORI), Pfizer, Genentech, and Vertex Pharmaceuticals, outside of the submitted work. MCa also declares royalties via revenue share from the commercial licence of Symptom Burden Questionnaire-Long COVID; payment or honoraria from the University of Maastricht, South-Eastern Norway Regional Health Authority, Cochrane Portugal, Singapore National Medical Research Council; and stock in GSK held by a family member. MCa has a leadership or fiduciary role in PROTEUS consortium (paid via a consultancy fee from Genetech and PCORI). TJP declares NIH awards (OT2OD032701 and R01EB030362), and grants or contracts from Google Cloud and Amazon Web Services. SK was an employee of Hardian Health. L-AF received consulting fees from Therapeutic Goods Administration, Australia, and WHO, and is a member of the AI in Healthcare Committee for Standards Australia and Director of Tethyan Consulting. CS received research funding from UKRI, NIHR, and the Wellcome Trust to support their research programme. BAM reports grants or contracts from MRC, the British Heart Foundation, the United States Agency for International Development, and HDRUK; consulting fees and support for attending meetings from the Bill & Melinda Gates Foundation; and was an employee of the Wellcome Trust at the time of the Delphi study. KH is an employee of Google Research. AK is an employee of Google and receives Google stock reimbursement. MM was an employee of Genomics England, Founder and Director of One HealthTech and Data Science for Health Equity (within One HealthTech), and received support from Nature Journals and Conde Nast. RP is an employee of MHRA. AKM is Deputy Editor of NEJM AI, NEJM Group. PM has a data custodian role as Director of the Clinical Practice Research Datalink and is an employee of MHRA. ZK was employed by Health Research Authority at the time of the consensus process. AAk received grants from the Economic and Social Care Research Council (ADR Wales ES/W012227/1) and HDRUK (HDR-9006). LB received support from the US National Institutes of Health (NIH) All of Us Research Programme to attend STANDING Together meetings. JWG is on the 2022 Robert Wood Johnson Foundation Harold Amos Medical Faculty Development Programme; declares support from the Radiological Society of North America Health Disparities grant (EIHD2204), Lacuna Fund (67), Gordon and Betty Moore Foundation, and NIH (NIBIB) Medical Imaging and Data Resource Center grant under contracts 75N92020C00008 and 75N92020C00021; has received honoraria from the National Bureau of Economic Research for authorship in their 2022 conference collection; has participated on the American Heart Association Deracing Algorithms advisory board; and is a board member of Hl7 and SIIM. LR is Senior Editor of the journal Nature Medicine, Nature Research, Springer Nature. MCh is an NIHR Academic Clinical Fellow. AAr is a panel member for various NIH Research committees, has received honoraria from HDRUK for attending panel meetings, and has an honorary affiliation with Moorfield's Eye Hospital. SP is employed by WHO. ES has had research funded by UK Research and Innovation (UKRI), NIHR, Wellcome Trust, Health Data Research UK (HDRUK), MRC, EPSRC, and Innovate UK, and declares support from the European Respiratory Society, British Thoracic Society, and Gilead. VT is Head of UK Approved Body as at the British Standards Institution. AD reports institutional research grants awarded by the NIHR, MRC, and EPSRC, and is an NIHR Senior Investigator, Director of the UK's incubator for Regulatory Science in AI and Digital Healthcare, deputy director of the Centre for Regulatory Science and Innovation, Birmingham Health Partners, system lead for AI diagnostics to NHS England, and a member of the UK Government's Regulatory Horizons Council. XL reports funding from the NIHR, the UK National Health Service AI Lab, The Health Foundation, Research England, the MHRA, the National Institute for Health and Care Excellence, and Hardian Health, and was previously a Health Studies Scientist at Apple; reports grants from the Medical Research Council, Wellcome Trust, NIHR, and Moorfields Eye Hospital Charity; received payment or honoraria for talks and book chapter reviews from the University of Turku and Elsevier; and received support from Harvard Medical School, SingHealth, and The Ada Lovelace Institute. All other authors declare no competing interests., (© 2024 World Health Organization. Published by Elsevier Ltd. This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.)